We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$336B
AUM Growth
+$8.51B
Cap. Flow
-$2.87B
Cap. Flow %
-0.85%
Top 10 Hldgs %
13.4%
Holding
4,442
New
125
Increased
1,853
Reduced
2,165
Closed
175

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Healthcare 13.54%
3 Financials 12.89%
4 Industrials 9.68%
5 Consumer Discretionary 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAT
4026
DELISTED
TransAtlantic Petroleum LTD.
TAT
$29K ﹤0.01%
23,830
-4,139
-15% -$3.65K
PERF
4027
DELISTED
Perfumania Holdings, Inc.
PERF
$29K ﹤0.01%
13,338
-2,225
-14% -$5.08K
NEON icon
4028
Neonode
NEON
$14.7M
$28K ﹤0.01%
2,465
-422
-15% -$5.72K
AXN
4029
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$28K ﹤0.01%
50,592
-544
-1% -$366
HEPA
4030
DELISTED
Hepion Pharmaceuticals
HEPA
0
ONCT
4031
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$27K ﹤0.01%
25
-3
-11% -$2.62K
IRD
4032
Opus Genetics
IRD
$319M
$26K ﹤0.01%
263
-40
-13% -$4.83K
CGRN
4033
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$25K ﹤0.01%
1,841
-315
-15% -$4.67K
GMO
4034
DELISTED
General Moly, Inc.
GMO
$25K ﹤0.01%
89,254
-15,613
-15% -$4.97K
CGNT
4035
DELISTED
Cogentix Medical, Inc.
CGNT
$25K ﹤0.01%
14,006
-2,552
-15% -$3.3K
STLY
4036
DELISTED
Stanley Furniture Co Inc
STLY
$25K ﹤0.01%
14,224
-2,530
-15% -$6.13K
GALT icon
4037
Galectin Therapeutics
GALT
$336M
$24K ﹤0.01%
21,171
-3,640
-15% -$6.47K
CTHR
4038
DELISTED
Charles & Colvard Ltd
CTHR
$24K ﹤0.01%
2,098
-355
-14% -$3.98K
YECO
4039
DELISTED
Yulong Eco-Materials Limited Ordinary Shares
YECO
$24K ﹤0.01%
2,100
PTX
4040
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$24K ﹤0.01%
3,833
-664
-15% -$4.09K
HTM
4041
DELISTED
U.S. Geothermal Inc.
HTM
$23K ﹤0.01%
5,304
-7,899
-60% -$37K
TEAR
4042
DELISTED
TearLab Corporation
TEAR
$22K ﹤0.01%
3,429
-598
-15% -$4.45K
BLRX
4043
BioLineRX
BLRX
$12.2M
$21K ﹤0.01%
31
+1
+3% +$533
GYRE icon
4044
Gyre Therapeutics
GYRE
$706M
$21K ﹤0.01%
156
-34
-18% -$5.13K
SMSI icon
4045
Smith Micro Software
SMSI
$16.7M
$21K ﹤0.01%
260
-55
-17% -$5.48K
SEEL
4046
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
VSR
4047
DELISTED
Versar, Inc.
VSR
$21K ﹤0.01%
13,963
-2,676
-16% -$3.83K
BONT
4048
DELISTED
Bon-Ton Stores Inc/The
BONT
$20K ﹤0.01%
11,570
-1,388
-11% -$2.19K
TPLM
4049
DELISTED
Triangle Petroleum Corporation
TPLM
$20K ﹤0.01%
72,584
-10,279
-12% -$2.57K
ACHV icon
4050
Achieve Life Sciences
ACHV
$733M
$19K ﹤0.01%
17
-3
-15% -$4.78K

Similar funds

Bank of New York Mellon's Q3 2016 Portfolio in Review

As of Q3 2016, Bank of New York Mellon held 4,442 positions worth $336B, up 2.6% from $328B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q3 2016 filing shows 125 new, 1,853 increased, 2,165 reduced and 175 closed positions. Its largest new stake was Fortive: 5,889,114 shares worth $189M. The largest sale was EMC CORPORATION, an estimated $518M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q3 2016 buy was Fortive: 5,889,114 shares worth $189M.
  • Bank of New York Mellon added most to Cerner Corp in Q3 2016, an estimated $392M increase.
  • Bank of New York Mellon's biggest Q3 2016 reduction was Sysco, cutting an estimated $291M.
  • Bank of New York Mellon fully exited EMC CORPORATION in Q3 2016, selling an estimated $518M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $336B portfolio in Q3 2016.
  • Bank of New York Mellon opened 125 new positions and closed 175 in Q3 2016.
  • Bank of New York Mellon's portfolio value rose 2.6% quarter-over-quarter to $336B.

Based on Bank of New York Mellon's 13F filing for Q3 2016, filed 3 Nov 2016.